Home
Scholarly Works
Phase II study of oral ridaforolimus in patients...
Conference

Phase II study of oral ridaforolimus in patients with metastatic and/or locally advanced recurrent endometrial cancer: NCIC CTG IND 192.

Authors

Mackay H; Welch S; Tsao MS; Biagi JJ; Elit L; Ghatage P; Martin LA; Tonkin KS; Ellard S; Lau SK

Volume

29

Publisher

AMER SOC CLINICAL ONCOLOGY

Publication Date

May 20, 2011

Conference proceedings

JOURNAL OF CLINICAL ONCOLOGY

Issue

15

ISSN

0732-183X

Labels

Fields of Research (FoR)

Contact the Experts team